THYROID SPECIFIC FORMULATIONS

Serial Number 90785190
Registration 6976844
700

Registration Progress

Application Filed
Jun 21, 2021
Under Examination
Approved for Publication
Nov 29, 2022
Published for Opposition
Nov 29, 2022
Registered
Feb 14, 2023

Trademark Image

THYROID SPECIFIC FORMULATIONS

Basic Information

Serial Number
90785190
Registration Number
6976844
Filing Date
June 21, 2021
Registration Date
February 14, 2023
Published for Opposition
November 29, 2022
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 14, 2023
Registration
Registered
Classes
005

Rights Holder

Thyroid Specific Formulations LLC

16
Address
Suite 100
9200 E. Raintree Dr.
Scottsdale, AZ 85260

Ownership History

Thyroid Specific Formulations LLC

Original Applicant
16
Scottsdale, AZ

Thyroid Specific Formulations LLC

Owner at Publication
16
Scottsdale, AZ

Thyroid Specific Formulations LLC

Original Registrant
16
Scottsdale, AZ

Legal Representation

Attorney
Daniel R. Pote

USPTO Deadlines

Next Deadline
1114 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230214)
Due Date
February 14, 2029
Grace Period Ends
August 14, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Feb 14, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 14, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 29, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 29, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 9, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 24, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 24, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 24, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 24, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Oct 24, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 13, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 12, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 12, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 12, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 12, 2022 GNRT O NON-FINAL ACTION E-MAILED Loading...
Sep 12, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 8, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 8, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 8, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 16, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 16, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 16, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 11, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 7, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 5, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 24, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Nutritional supplements; Dietary supplements
First Use Anywhere: Jun 17, 2021
First Use in Commerce: Jun 17, 2021

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THYROID SPECIFIC FORMULATIONS"